دورية أكاديمية
Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.
| العنوان: | Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. |
|---|---|
| المؤلفون: | Hong YP; Yu-Peng Hong, Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China., Li ZD; Yu-Peng Hong, Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China., Prasoon P; Yu-Peng Hong, Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China., Zhang Q; Yu-Peng Hong, Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China. |
| المصدر: | World journal of hepatology [World J Hepatol] 2015 May 08; Vol. 7 (7), pp. 980-92. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101532469 Publication Model: Print Cited Medium: Print ISSN: 1948-5182 (Print) NLM ISO Abbreviation: World J Hepatol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group Original Publication: Beijing, China : Baishideng |
| مستخلص: | Hepatocellular carcinoma (HCC) is a common cancer worldwide with a poor prognosis. Few strategies have been proven efficient in HCC treatment, particularly for those patients not indicated for curative resection or transplantation. Immunotherapy has been developed for decades for cancer control and is attaining more attention as a result of encouraging outcomes of new strategies such as chimeric antigen receptor T cells and immune checkpoint blockade. Right at the front of the new era of immunotherapy, we review the immunotherapy in HCC treatment, from basic research to clinical trials, covering anything from immunomodulators, tumor vaccines and adoptive immunotherapy. The mechanisms, efficacy and safety as well as the approach particulars are unveiled to assist readers to gain a concise but extensive understanding of immunotherapy of HCC. |
| References: | J Immunother. 2005 Sep-Oct;28(5):496-504. (PMID: 16113606) Leuk Lymphoma. 2003 Sep;44(9):1457-62. (PMID: 14565644) Hepatology. 2011 Mar;53(3):1020-2. (PMID: 21374666) Science. 2006 Sep 29;313(5795):1972-5. (PMID: 16931720) Sci Rep. 2014 Jun 05;4:5177. (PMID: 24898887) Semin Surg Oncol. 2000 Sep-Oct;19(2):135-44. (PMID: 11126378) Cell Immunol. 2009;259(1):13-20. (PMID: 19545862) Nat Rev Immunol. 2004 Mar;4(3):231-7. (PMID: 15039760) Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71. (PMID: 11698646) J Immunol. 2007 Jan 1;178(1):574-83. (PMID: 17182598) Chin J Cancer. 2010 Feb;29(2):172-7. (PMID: 20109346) Curr Opin Immunol. 2002 Apr;14(2):165-71. (PMID: 11869887) Clin Immunol. 2005 Feb;114(2):174-82. (PMID: 15639651) J Clin Oncol. 2007 Jun 20;25(18):2586-93. (PMID: 17577038) Mol Ther. 2013 Apr;21(4):904-12. (PMID: 23423337) Curr Opin Immunol. 2009 Apr;21(2):215-23. (PMID: 19327974) J Immunother. 2005 Mar-Apr;28(2):129-35. (PMID: 15725956) Hepatology. 1993 Mar;17 (3):389-94. (PMID: 8383088) Expert Opin Biol Ther. 2012 Jun;12(6):673-84. (PMID: 22500889) Mol Clin Oncol. 2013 Jul;1(4):593-598. (PMID: 24649215) J Immunol. 2003 Aug 15;171(4):1775-9. (PMID: 12902477) Clin Cancer Res. 2007 Feb 1;13(3):902-11. (PMID: 17289884) J Clin Oncol. 2004 Apr 15;22(8):1389-97. (PMID: 15084613) Am J Gastroenterol. 2000 Mar;95(3):748-52. (PMID: 10710069) Hepatology. 2009 May;49(5 Suppl):S103-11. (PMID: 19399806) Immunol Lett. 2013 Sep-Oct;155(1-2):27-30. (PMID: 24084446) Hepatology. 2014 Apr;59(4):1448-58. (PMID: 24122861) J Hepatol. 1999 Aug;31(2):323-31. (PMID: 10453947) Biol Blood Marrow Transplant. 2001;7(4):216-22. (PMID: 11349808) J Cancer Res Clin Oncol. 2006 May;132(5):293-301. (PMID: 16421755) J Gastroenterol Hepatol. 2002 Aug;17(8):889-96. (PMID: 12164965) Cancer Lett. 2012 May 28;318(2):154-61. (PMID: 22182446) Hum Pathol. 2006 Mar;37(3):332-8. (PMID: 16613328) Cancer. 2013 Jun 15;119(12 ):2239-46. (PMID: 23564564) Biochem Biophys Res Commun. 2012 Jun 15;422(4):687-92. (PMID: 22634008) Gastroenterology. 2010 May;138(5):1931-42. (PMID: 20060829) J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S272-83. (PMID: 20061007) Exp Hematol Oncol. 2012 Apr 26;1(1):11. (PMID: 23210562) Blood. 2008 Sep 15;112(6):2563-74. (PMID: 18565854) Cancer Res. 2006 Nov 15;66(22):10995-1004. (PMID: 17108138) Mol Ther. 2010 Apr;18(4):843-51. (PMID: 20179677) Expert Opin Biol Ther. 2009 Jul;9(7):831-40. (PMID: 19463075) Am J Clin Oncol. 1995 Jun;18(3):257-62. (PMID: 7747715) J Gastroenterol Hepatol. 2000 Apr;15(4):431-6. (PMID: 10824889) Clin Dev Immunol. 2011;2011:249281. (PMID: 21969837) J Immunol. 2008 Mar 15;180(6):3627-35. (PMID: 18322166) Immunology. 2005 Aug;115(4):451-61. (PMID: 16011514) J Transl Med. 2013 Mar 28;11:83. (PMID: 23536996) Hepatology. 2009 Sep;50(3):799-807. (PMID: 19551844) Immunotherapy. 2011 Apr;3(4 Suppl):32-4. (PMID: 21524167) N Engl J Med. 2013 Apr 18;368(16):1509-18. (PMID: 23527958) Vaccine. 2007 Sep 28;25(39-40):6911-21. (PMID: 17728021) Int J Oncol. 2012 Nov;41(5):1601-9. (PMID: 22971679) J Cancer. 2011;2:363-8. (PMID: 21716717) J Clin Invest. 2011 May;121(5):1822-6. (PMID: 21540550) J Exp Med. 1991 Jul 1;174(1):139-49. (PMID: 1711560) Langenbecks Arch Surg. 2012 Jun;397(5):673-80. (PMID: 21479622) N Engl J Med. 2011 Aug 25;365(8):725-33. (PMID: 21830940) J Natl Cancer Inst. 2005 Oct 19;97(20):1532-8. (PMID: 16234567) Ann Surg Oncol. 2013 Dec;20(13):4305-11. (PMID: 23892527) Nat Immunol. 2002 Nov;3(11):1097-101. (PMID: 12368911) Hum Gene Ther. 2009 Nov;20(11):1229-39. (PMID: 19702437) Leukemia. 2014 Aug;28(8):1596-605. (PMID: 24504024) Recent Results Cancer Res. 2009;181:85-94. (PMID: 19213561) Hepatology. 2000 Jan;31(1):54-8. (PMID: 10613728) J Hepatol. 2011 May;54(5):948-55. (PMID: 21145847) Clin Cancer Res. 2006 May 1;12(9):2689-97. (PMID: 16675560) J Gene Med. 2012 Jun;14(6):405-15. (PMID: 22262649) Liver Int. 2009 Sep;29(8):1162-70. (PMID: 19627485) J Hepatol. 2011 Jul;55(1):103-10. (PMID: 21145860) J Clin Oncol. 2006 May 1;24(13):e20-2. (PMID: 16648493) Cancer Lett. 2012 Jan 28;314(2):213-22. (PMID: 22056812) N Engl J Med. 2013 Jul 11;369(2):134-44. (PMID: 23724846) J Immunol. 1999 Nov 15;163(10):5211-8. (PMID: 10553041) Gastroenterology. 2014 Sep;147(3):577-594.e1. (PMID: 25066692) J Exp Med. 2009 Dec 21;206(13):3015-29. (PMID: 20008522) J Hepatol. 2013 Jul;59(1):81-8. (PMID: 23466307) Clin Immunol. 2008 Dec;129(3):428-37. (PMID: 18824414) J Immunother Emphasis Tumor Immunol. 1996 May;19(3):218-23. (PMID: 8811496) Tumour Biol. 2013 Oct;34(5):3027-34. (PMID: 23907578) J Clin Oncol. 2010 Oct 10;28(29):4531-8. (PMID: 20516428) World J Gastroenterol. 2002 Jun;8(3):464-8. (PMID: 12046071) Clin Exp Immunol. 2007 Feb;147(2):296-305. (PMID: 17223971) Can J Gastroenterol. 2013 Jun;27(6):351-63. (PMID: 23781519) Mol Ther. 2010 Apr;18(4):666-8. (PMID: 20357779) Nat Rev Cancer. 2002 Nov;2(11):850-61. (PMID: 12415255) Hepatology. 2009 Jan;49(1):124-32. (PMID: 18980227) Hepatology. 2006 Feb;43(2):362-72. (PMID: 16440347) J Hepatol. 2010 Jun;52(6):889-94. (PMID: 20395009) Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1330-3. (PMID: 1658591) Ann Surg. 2012 Jan;255 (1):8-17. (PMID: 22104564) Int J Cancer. 2010 May 1;126(9):2164-74. (PMID: 19739081) Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6106-15. (PMID: 17062687) J Hepatol. 2005 Dec;43(6):1013-20. (PMID: 16168521) J Interferon Cytokine Res. 1995 May;15(5):467-72. (PMID: 7544232) J Immunother. 2008 Jan;31(1):63-71. (PMID: 18157013) Cancer Biol Ther. 2010 Aug 15;10 (4):368-75. (PMID: 20581468) Gastroenterology. 2007 Jun;132(7):2328-39. (PMID: 17570208) Nat Biotechnol. 2012 Jul 10;30(7):611-4. (PMID: 22781680) Cancer Biol Ther. 2011 Mar 1;11(5):450-6. (PMID: 21258206) Am J Transl Res. 2014 Jul 18;6(4):340-52. (PMID: 25075251) Annu Rev Immunol. 2007;25:297-336. (PMID: 17150027) J Gastroenterol Hepatol. 2009 Aug;24(8):1437-44. (PMID: 19486255) Cytotherapy. 2012 Apr;14(4):483-93. (PMID: 22277010) Virology. 2014 Aug;462-463:343-50. (PMID: 25019494) Int J Cancer. 2009 Oct 1;125(7):1640-8. (PMID: 19569243) Clin Cancer Res. 2004 Oct 15;10(20):6946-55. (PMID: 15501973) Liver Cancer. 2012 Nov;1(3-4):226-37. (PMID: 24159587) Dig Liver Dis. 2009 Jan;41(1):36-41. (PMID: 18818130) Cancer Immunol Immunother. 2007 Jul;56(7):1009-16. (PMID: 17186291) Gut. 2012 Mar;61(3):427-38. (PMID: 21930732) Nat Rev Immunol. 2004 Dec;4(12):941-52. (PMID: 15573129) Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5902-8. (PMID: 14676113) Science. 2007 Aug 3;317(5838):627-9. (PMID: 17673654) Cancer Res. 2006 Nov 15;66(22):11005-12. (PMID: 17108139) J Transl Med. 2014 Apr 05;12:86. (PMID: 24708667) Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):583-91. (PMID: 24924902) Hum Vaccin Immunother. 2013 Jan;9(1):210-2. (PMID: 23442593) Int J Mol Sci. 2014 Apr 16;15(4):6441-52. (PMID: 24743888) Cytotherapy. 2006;8(6):580-8. (PMID: 17148035) Rev Recent Clin Trials. 2008 Jan;3(1):31-9. (PMID: 18474013) J Hepatol. 2009 May;50(5):980-9. (PMID: 19329213) Trends Mol Med. 2012 Jul;18(7):377-84. (PMID: 22613370) Cancer Immunol Immunother. 2012 Jul;61(7):953-62. (PMID: 22527245) Eur J Immunol. 2006 Jun;36(6):1413-22. (PMID: 16708397) Hepatology. 2002 Nov;36(5):1115-24. (PMID: 12395321) Int J Oncol. 2007 Jan;30(1):201-8. (PMID: 17143530) Hepatology. 2014 Nov;60(5):1776-82. (PMID: 24912948) Hepatogastroenterology. 2014 Mar-Apr;61(130):278-84. (PMID: 24901124) J Immunother. 2013 Jun;36(5):287-93. (PMID: 23719239) J Leukoc Biol. 2006 Dec;80(6):1197-213. (PMID: 16946019) Cancer Immunol Immunother. 2007 Dec;56(12):1875-83. (PMID: 17479266) Mol Biol (Mosk). 2012 May-Jun;46(3):434-51. (PMID: 22888633) Digestion. 2012;86(4):329-37. (PMID: 23207161) J Cancer Res Clin Oncol. 2013 Jan;139(1):39-48. (PMID: 22886490) Cancer. 2012 Jul 1;118(13):3302-10. (PMID: 22072099) Cancer Res. 2009 Feb 1;69(3):855-62. (PMID: 19141642) World J Gastroenterol. 2006 May 28;12 (20):3275-82. (PMID: 16718852) Cancer Immunol Immunother. 1998 Dec;47(4):221-6. (PMID: 9875675) Oncogene. 2012 Apr 26;31(17):2140-52. (PMID: 21927025) Cancer Immunol Immunother. 2003 Mar;52(3):155-61. (PMID: 12649744) BMC Cancer. 2010 May 17;10:209. (PMID: 20478057) |
| فهرسة مساهمة: | Keywords: Adoptive immunotherapy; Checkpoint blockade; Chemokine; Chimeric antigen receptor; Interferon; Tumor vaccine |
| تواريخ الأحداث: | Date Created: 20150509 Date Completed: 20150508 Latest Revision: 20201001 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC4419101 |
| DOI: | 10.4254/wjh.v7.i7.980 |
| PMID: | 25954480 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1948-5182 |
|---|---|
| DOI: | 10.4254/wjh.v7.i7.980 |